AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
760 - Dr. Scott Gottlieb (Part 2): Uncontrolled Spread: How We Can Defeat the Next Pandemic
The James Altucher Show
Do You Think the FDA Should Have Done More Testing?
3min Snip
00:00
Summary
Transcript
Episode notes
There are mechanisms to provide drugs earlier patients while it is still in clinical development. Companies don't offer expanded access because they worry that it will disncentivize people from entering a trial. In oncology, when i was at the agency, we stood up and said, we're not going to do placiba trials any more. But why even have a stage three or stage four like, just let me choose, and then the data will show from population data? It's unethical in the setting of a disease that we know is terminal to radomize patients to a placebo pill.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode